Cargando…

False-Negative Bone Scan and Choline Pet/Ct Study in a Case of Prostate Cancer: The Pitfall of the Small Cell Prostate Carcinoma Variant

We present a rare variant of prostate carcinoma. The patient is a 45-year-old male with elevated prostate-specific antigen levels at screening. Magnetic resonance imaging revealed hyperenhancing lesions throughout the axial skeleton. The fluorine-18 fluorocholine (FCH) positron emission tomography/c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Tamimi, Ammad, Tan, Andrew Eik Hock, Kwong, Sidney Yu Wing, Sam, Christopher Cheng Wai, Chong, Angela, Tan, Cher Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555398/ https://www.ncbi.nlm.nih.gov/pubmed/23372441 http://dx.doi.org/10.4103/1450-1147.103422

Ejemplares similares

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
por: Tan, Chjoong Howe Alvin, et al.
Publicado: (2012)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
por: O'Connor, Ellen, et al.
Publicado: (2020)

Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?
por: Jadvar, Hossein
Publicado: (2012)

False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial
por: Fendler, Wolfgang P., et al.
Publicado: (2020)

Detection rates of recurrent prostate cancer: (68)Gallium (Ga)-labelled prostate-specific membrane antigen versus choline PET/CT scans. A systematic review
por: Moghul, Masood, et al.
Publicado: (2019)

Choline PET based dose-painting in prostate cancer - Modelling of dose effects
por: Niyazi, Maximilian, et al.
Publicado: (2010)

Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma
por: Hodolic, Marina
Publicado: (2010)

Dynamic (11)C-Choline PET / CT for the primary diagnosis of prostate cancer
por: Golan, Shay, et al.
Publicado: (2018)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review
por: Skanjeti, Andrea, et al.
Publicado: (2011)

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
por: Massaro, Arianna, et al.
Publicado: (2012)

Cerebellar Metastases from Prostate Cancer Detected by PET/CT with (18)F-Choline
por: Filippi, Luca, et al.
Publicado: (2022)

False Positive and False Negative FDG-PET Scans in Various Thoracic Diseases
por: Chang, Jung Min, et al.
Publicado: (2006)

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer
por: Mathieu, Cédric, et al.
Publicado: (2015)

Occult Prostate Cancer Detected with 18F-Fluorocholine Positron Emission Tomography/Computed Tomography
por: Xie, Wanying, et al.
Publicado: (2014)

Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
por: Li, Huanye, et al.
Publicado: (2022)

Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients
por: Huysse, Wouter, et al.
Publicado: (2017)

Clinical Indications of (11)C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
por: Picchio, Maria, et al.
Publicado: (2012)

Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach
por: Lee, Chau Hung, et al.
Publicado: (2021)

18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
por: Urso, Luca, et al.
Publicado: (2022)

False-positive FDG PET CT Scan in Vertebral Hemangioma
por: Solav, Shrikant Vasantrao, et al.
Publicado: (2019)

Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?
por: Hermann, Robert M., et al.
Publicado: (2016)

Interpretation of 11C–choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer
por: Matti, A., et al.
Publicado: (2017)

Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer
por: Huang, Shi-ming, et al.
Publicado: (2018)

Accurate Monitoring of the Response of Bone Metastases to Treatment in Patients with Prostate Cancer Using Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous (18)F-choline PET/MRI for prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2018)

Accuracy of tumor segmentation from multi-parametric prostate MRI and (18)F-choline PET/CT for focal prostate cancer therapy applications
por: Piert, Morand, et al.
Publicado: (2018)

False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance
por: Quon, Jeffrey S., et al.
Publicado: (2015)

PET/CT analysis of 21 patients with breast cancer: physiological distribution of (18)F-choline and diagnostic pitfalls
por: Ahmad Saad, Fathinul Fikri, et al.
Publicado: (2018)

Correction to: impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous (18)F-choline PET/MRI for prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2018)

Metabolic Volumetric Parameters in (11)C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer
por: Tseng, Jing-Ren, et al.
Publicado: (2018)

Effect of positive carbon-11-choline PET/CT results in the therapeutic management of prostate cancer biochemical relapse
por: Gómez-de la Fuente, Francisco J., et al.
Publicado: (2019)

(18)F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
por: Urbano, Nicoletta, et al.
Publicado: (2019)

Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore
por: Cheng, Li-Jen, et al.
Publicado: (2021)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
por: Leow, Jeffrey J, et al.
Publicado: (2022)

Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [(18)F] Choline PET/MRI
por: Wetter, Axel, et al.
Publicado: (2014)

Value of (11)C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases
por: Zhou, Shuoming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tst0udnege4nmscpll20oe9ver